Ascension | Ascension Texas Cardiovascular

Research site

(Unclaimed)

Location

1301 West 38th Street Suite. 400, Austin, Texas, United States of America

Site insights

Top conditions

Top treatments

Ralinepag

Apixaban

EVOLocumab

Zenagamtide

Diuretic

Parent organization

This site is a part of Ascension

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

10 of 15 total trials

A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity (AMBIENCE)

This clinical study is being conducted to evaluate the safety and effectiveness of zenagamtide in people with atherosclerotic cardiovascular disease...

Begins enrollment this month

Obesity

Cardiovascular Risk

Drug: Zenagamtide

Drug: Placebo

A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

Study ROR-PH-303, ADVANCE EXTENSION, is an open-label extension (OLE) study for participants with WHO Group 1 PAH who have participated in another Ph...

Invitation-only

Hypertension

Familial Primary Pulmonary Hypertension

Drug: Ralinepag

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation (LIBREXIA-AF)

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Active, not recruiting

Atrial Fibrillation

Drug: Apixaban Placebo

Drug: Milvexian

A Study to Predict Atrial Fibrillation (AF) Burden in Participants With PAF and PsAF Treated With the VARIPULSE™ PFA Catheter (SPECTRA-AF)

The purpose of this study is to evaluate how safe VARIPULSE™ Catheter is and how well it works in the treatment of participants with symptomatic paro...

Begins enrollment this month

Atrial Fibrillation

Device: VARIPULSE Catheter System (PVI and PWI)

Device: VARIPULSE Catheter System (PVI)

Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II (COSIRA-II)

To demonstrate the safety and effectiveness of the Shockwave Reducer for treatment of patients with refractory angina pectoris treated with maximally...

Enrolling

Refractory Angina

Device: Arm 3 (unblinded, non-randomized): Single arm registry

Other: Arm 2 (control): Implantation procedure with no device implanted

ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation

The objective of ENVISION is to evaluate the safety and effectiveness of the Navitor Transcatheter Aortic Valve Implantation (TAVI) System for treati...

Invitation-only

Heart Valve Diseases

Aortic Valve Stenosis

Device: Navitor Transcatheter Aortic Valve Implantation (TAVI) System

Device: Any Commercially Available Transcatheter Aortic Valve (CAV) System

EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction

The primary objective of this study is to evaluate the effectiveness of early treatment with evolocumab plus routine lipid management vs routine lipi...

Active, not recruiting

Stroke

Myocardial Infarction

Drug: Evolocumab

Drug: Routine Lipid Management

MitraClip REPAIR MR Study

The objective of this randomized controlled trial (RCT) is to compare the clinical outcome of MitraClip™ device versus surgical repair in patients wi...

Active, not recruiting

Mitral Valve Regurgitation

Device: MitraClip™ device implantation

Procedure: Mitral Valve Repair Surgery

PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

This study objective is to establish the safety and effectiveness of the Edwards SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA Transcatheter Hea...

Enrolling

Aortic Valve Stenosis

Aortic Stenosis, Calcific

Device: SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure (TEAM-HF)

The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical ther...

Enrolling

Cardiovascular Diseases

Heart Failure

Other: Guideline Medical Directed Therapy

Device: HeartMate 3 Left Ventricular Assist System